Volume 21, Issue 12 p. 1021-1030
Review

β-catenin signaling and cancer

Patrice J. Morin

Patrice J. Morin

Laboratory of Biological Chemistry, Gerontology Research Center, National Institute on Aging, 5600 Nathan Shock Drive, Baltimore, MD 21224, and Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287.

Search for more papers by this author

This article is a US Government work and, as such, is in the public domain in the United States of America.

Abstract

Since its discovery as a protein associated with the cytoplasmic region of E-cadherin, β-catenin has been shown to perform two apparently unrelated functions: it has a crucial role in cell–cell adhesion in addition to a signaling role as a component of the Wnt/wg pathway. Wnt/wg signaling results in β-catenin accumulation and transcriptional activation of specific target genes during development. It is now apparent that deregulation of β-catenin signaling is an important event in the genesis of a number of malignancies, such as colon cancer, melanoma, hepatocellular carcinoma, ovarian cancer, endometrial cancer, medulloblastoma pilomatricomas, and prostate cancer. β-catenin mutations appear to be a crucial step in the progression of a subset of these cancers, suggesting an important role in the control of cellular proliferation or cell death. The APC/β-catenin pathway is highly regulated and includes players such as GSK3-β, CBP, Groucho, Axin, Conductin, and TCF. c-MYC and cyclin D1 were recently identified as a key transcriptional targets of this pathway and additional targets are likely to emerge. BioEssays 21:1021–1030, 1999. Published 1999 John Wiley & Sons, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.